CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project fosters collaboration between pharmaceutical companies and universities to enhance drug discovery and development. It focuses on training scientists in both academic and industrial settings, particularly in the design of new antituberculosis drugs.
The establishment of influential public and private public partnerships fostering true collaboration between big Pharma and universities for a non-profit end goal has opened the door for stronger interaction and integration.
This structural change has come to stay and is slowly permeating other sectors in which the commercial return on investment is clear (Drug.
Discov.
Today, 2009, 14, 1003).
This new paradigm is also creating opportunities for young scientists to experience and understand both…
UNIVERSITEIT ANTWERPEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Tres Cantos
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
